1. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases;Patrignani;J Pharmacol Exp Ther,1994
2. A. Basic biology and clinical application of specific COX-2 inhibitors;Crofford;Arthritis Rheum,2000
3. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2;Riendeau;J Pharmacol Exp Ther,2000
4. N〚(5-methyl-3-phenylisoxazol-4-yl)-phenyl〛sulfonyl〛 propanamide, sodium salt, parecoxib sodium: a potent and selective inhibitor of COX-2 for parenteral administration;Talley;J Med Chem,2000
5. 4 〚5-Methyl-3-phenylisoxazol-4-yl〛-benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2;Talley;J Med Chem,2000